Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dieter

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Cells|February 13, 2019
Systematic Generation of Patient-Derived Tumor Models in Pancreatic CancerKarl Roland Ehrenberg, Jianpeng Gao, Felix Oppel, et al.
Cancers|April 3, 2021
Functional States in Tumor-Initiating Cell Differentiation in Human Colorectal CancerMartina K Zowada, Stephan M Tirier, Sebastian M Dieter, et al.
The Journal of Experimental Medicine|June 3, 2017
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancerKlara M Giessler, Kortine Kleinheinz, Daniel Huebschmann, et al.
Genome Biology|January 30, 2021
A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesisLi Li, Alejandro P Ugalde, Colinda L G J Scheele, et al.
International Journal of Cancer|December 10, 2016
Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferationSebastian M Dieter, Klara M Giessler, Mark Kriegsmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinomaS M Dieter, C Heining, A Agaimy, et al.
Cell Reports|July 21, 2021
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancerSebastian M Dieter, Christine Siegl, Paula L Codó, et al.
Nature Genetics|November 22, 2016
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijackingJoachim Weischenfeldt, Taronish Dubash, Alexandros P Drainas, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Cells|February 13, 2019
Systematic Generation of Patient-Derived Tumor Models in Pancreatic CancerKarl Roland Ehrenberg, Jianpeng Gao, Felix Oppel, et al.
Cancers|April 3, 2021
Functional States in Tumor-Initiating Cell Differentiation in Human Colorectal CancerMartina K Zowada, Stephan M Tirier, Sebastian M Dieter, et al.
The Journal of Experimental Medicine|June 3, 2017
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancerKlara M Giessler, Kortine Kleinheinz, Daniel Huebschmann, et al.
Genome Biology|January 30, 2021
A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesisLi Li, Alejandro P Ugalde, Colinda L G J Scheele, et al.
International Journal of Cancer|December 10, 2016
Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferationSebastian M Dieter, Klara M Giessler, Mark Kriegsmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinomaS M Dieter, C Heining, A Agaimy, et al.
Cell Reports|July 21, 2021
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancerSebastian M Dieter, Christine Siegl, Paula L Codó, et al.
Nature Genetics|November 22, 2016
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijackingJoachim Weischenfeldt, Taronish Dubash, Alexandros P Drainas, et al.
Pageof 4